Published in Virology on September 30, 1998
The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A (2000) 5.46
Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol (1999) 4.32
Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells. PLoS Biol (2011) 2.02
Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe (2013) 1.97
Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. J Virol (2002) 1.71
VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment. J Virol (2002) 1.63
VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice. Antimicrob Agents Chemother (2006) 1.63
Assembly and budding of Ebolavirus. PLoS Pathog (2006) 1.62
Development and characterization of a mouse model for Marburg hemorrhagic fever. J Virol (2009) 1.62
Ultrastructural organization of recombinant Marburg virus nucleoprotein: comparison with Marburg virus inclusions. J Virol (2000) 1.55
Multivesicular bodies as a platform for formation of the Marburg virus envelope. J Virol (2004) 1.47
VP24 of Marburg virus influences formation of infectious particles. J Virol (2005) 1.46
The matrix protein of Marburg virus is transported to the plasma membrane along cellular membranes: exploiting the retrograde late endosomal pathway. J Virol (2004) 1.43
Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription. J Virol (2010) 1.39
Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography. Proc Natl Acad Sci U S A (2012) 1.38
Forty-five years of Marburg virus research. Viruses (2012) 1.34
Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription. J Virol (2005) 1.30
Development of a model for marburgvirus based on severe-combined immunodeficiency mice. Virol J (2007) 1.30
VP40 octamers are essential for Ebola virus replication. J Virol (2005) 1.28
The N terminus of Rift Valley fever virus nucleoprotein is essential for dimerization. J Virol (2005) 1.23
Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30. J Virol (2006) 1.15
Mapping of the VP40-binding regions of the nucleoprotein of Ebola virus. J Virol (2007) 1.14
The Ebola virus genomic replication promoter is bipartite and follows the rule of six. J Virol (2005) 1.14
The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified. Virus Res (2008) 1.13
Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of Marburg virus-like particles. J Virol (2010) 1.12
The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells. Sci Rep (2013) 1.11
Filovirus replication and transcription. Future Virol (2007) 1.09
Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function. J Virol (2010) 1.07
Role of the transmembrane domain of marburg virus surface protein GP in assembly of the viral envelope. J Virol (2007) 1.06
Sorting of Marburg virus surface protein and virus release take place at opposite surfaces of infected polarized epithelial cells. J Virol (2001) 1.05
Establishment of fruit bat cells (Rousettus aegyptiacus) as a model system for the investigation of filoviral infection. PLoS Negl Trop Dis (2010) 1.04
Ebolavirus VP35 is a multifunctional virulence factor. Virulence (2010) 1.02
Intracellular events and cell fate in filovirus infection. Viruses (2011) 1.01
Structure and functional analysis of the RNA- and viral phosphoprotein-binding domain of respiratory syncytial virus M2-1 protein. PLoS Pathog (2012) 0.98
Electron tomography reveals the steps in filovirus budding. PLoS Pathog (2010) 0.97
DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function. J Infect Dis (2011) 0.91
The importance of the NP: VP35 ratio in Ebola virus nucleocapsid formation. J Infect Dis (2011) 0.90
The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals. Virology (2013) 0.89
Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus. Med Microbiol Immunol (2003) 0.88
Oligomerization of Uukuniemi virus nucleocapsid protein. Virol J (2010) 0.87
Nucleocapsid formation and RNA synthesis of Marburg virus is dependent on two coiled coil motifs in the nucleoprotein. Virol J (2007) 0.87
Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum. Virol J (2011) 0.85
Ebola virus VP35 interaction with dynein LC8 regulates viral RNA synthesis. J Virol (2015) 0.84
Live-cell imaging of Marburg virus-infected cells uncovers actin-dependent transport of nucleocapsids over long distances. Proc Natl Acad Sci U S A (2013) 0.83
Interaction with Tsg101 is necessary for the efficient transport and release of nucleocapsids in marburg virus-infected cells. PLoS Pathog (2014) 0.83
Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread. J Infect Dis (2011) 0.83
Novel phosphoprotein-interacting region in Nipah virus nucleocapsid protein and its involvement in viral replication. J Virol (2010) 0.83
Genus-specific recruitment of filovirus ribonucleoprotein complexes into budding particles. J Gen Virol (2011) 0.82
Ebola virus entry into host cells: identifying therapeutic strategies. Curr Clin Microbiol Rep (2015) 0.82
Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis. J Mol Biol (2016) 0.79
The cytoplasmic domain of Marburg virus GP modulates early steps of viral infection. J Virol (2011) 0.79
Determination of specific antibody responses to the six species of ebola and marburg viruses by multiplexed protein microarrays. Clin Vaccine Immunol (2014) 0.78
The Ebola Virus VP30-NP Interaction Is a Regulator of Viral RNA Synthesis. PLoS Pathog (2016) 0.77
Nucleocytoplasmic transport of nucleocapsid proteins of enveloped RNA viruses. Front Microbiol (2015) 0.77
Molecular Mechanisms of Innate Immune Inhibition by Non-Segmented Negative-Sense RNA Viruses. J Mol Biol (2016) 0.76
Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 peptide in Marburg virus. J Virol (2017) 0.76
Marburg Virus Reverse Genetics Systems. Viruses (2016) 0.75
Crystal Structure of the Marburg Virus VP35 Oligomerization Domain. J Virol (2016) 0.75
HUMAN METAPNEUMOVIRUS INDUCES FORMATION OF INCLUSION BODIES FOR EFFICIENT GENOME REPLICATION AND TRANSCRIPTION. J Virol (2017) 0.75
Crystal Structure of the Marburg Virus Nucleoprotein Core Domain Chaperoned by a VP35 Peptide Reveals a Conserved Drug Target for Filovirus. J Virol (2017) 0.75
From hybridomas to a robust microalgal-based production platform: molecular design of a diatom secreting monoclonal antibodies directed against the Marburg virus nucleoprotein. Microb Cell Fact (2017) 0.75
Intracellular Crosslinking of Filoviral Nucleoproteins with Xintrabodies Restricts Viral Packaging. Front Immunol (2017) 0.75
The study of transcription and replication of the Marburg virus using a minireplicon system constructed on the basis of viral genome [corrected]. Dokl Biochem Biophys (2002) 0.75
Activation of influenza A viruses by trypsin treatment. Virology (1975) 8.07
The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A (2000) 5.46
GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology (1995) 5.34
Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J (1992) 5.05
Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology (1976) 4.85
Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A (1998) 4.33
Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol (1999) 4.32
Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature (1992) 4.16
Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. Virology (1970) 3.58
The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc Natl Acad Sci U S A (2001) 3.43
The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses. Virology (1979) 3.25
Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science (2001) 3.08
Presence of murine leukemia virus envelope proteins gp70 and p15(E) in a common polyprotein of infected cells. J Virol (1976) 2.91
Inhibition of glycoprotein biosynthesis of influenza virus by D-glucosamine and 2-deoxy-D-glucose. Virology (1972) 2.84
Two independent targeting signals in the cytoplasmic domain determine trans-Golgi network localization and endosomal trafficking of the proprotein convertase furin. EMBO J (1995) 2.76
Influenza viruses cause hemolysis and fusion of cells. Virology (1981) 2.73
Glycosphingolipids of plasma membranes of cultured cells and an enveloped virus (SV5) grown in these cells. Proc Natl Acad Sci U S A (1970) 2.73
Glycolipid content of vesicular stomatitis virus grown in baby hamster kidney cells. J Virol (1971) 2.68
The proteins of the parainfluenza virus SV5. 1. Separation of virion polypeptides by polyacrylamide gel electrophoresis. Virology (1969) 2.50
Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology (1994) 2.48
Lipids of plasma membranes of monkey and hamster kidney cells and of parainfluenza virions grown in these cells. Virology (1969) 2.48
Molecular biology and evolution of filoviruses. Arch Virol Suppl (1993) 2.45
The proteins of the parainfluenza virus SV5. II. The carbohydrate content and glycoproteins of the virion. Virology (1970) 2.37
Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res (1992) 2.29
Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol (1996) 2.26
How to overcome resistance of influenza A viruses against adamantane derivatives. Antiviral Res (1998) 2.25
Pause on avian flu transmission research. Science (2012) 2.24
Molecular characterization of guinea pig-adapted variants of Ebola virus. Virology (2000) 2.21
Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein. J Virol (1994) 2.17
Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage. Virology (1981) 2.13
Glycosylation and oligomerization of the spike protein of Marburg virus. Virology (1991) 2.11
Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics. J Virol (2000) 2.09
Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. J Virol (1997) 2.09
Crystal structure of the matrix protein VP40 from Ebola virus. EMBO J (2000) 2.08
Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones. Biochimie (1994) 2.07
Association of influenza virus proteins with cytoplasmic fractions. Virology (1974) 2.00
Activation of precursors to both glycoporteins of Newcastle disease virus by proteolytic cleavage. Virology (1977) 2.00
Studies on the adaptation of influenza viruses to MDCK cells. EMBO J (1984) 1.98
Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector. EMBO J (1986) 1.98
The function of the neuraminidase in membrane fusion induced by myxoviruses. Virology (1980) 1.97
Role of Staphylococcus protease in the development of influenza pneumonia. Nature (1987) 1.96
Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells. J Biol Chem (1986) 1.92
Infection and activation of monocytes by Marburg and Ebola viruses. J Virol (2001) 1.90
An electron microscopic study of the presence or absence of neuraminic acid in enveloped viruses. Virology (1970) 1.88
The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis. Arch Virol Suppl (1999) 1.87
Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein. J Virol (1993) 1.85
Biosynthesis and role of filoviral glycoproteins. J Gen Virol (2001) 1.84
Mutations at the cleavage site of the hemagglutinin after the pathogenicity of influenza virus A/chick/Penn/83 (H5N2). Virology (1989) 1.81
Marburg and Ebola viruses. Adv Virus Res (1996) 1.81
Inhibition of glycosylation of the influenza virus hemagglutinin. J Virol (1974) 1.81
Maturation of the trans-Golgi network protease furin: compartmentalization of propeptide removal, substrate cleavage, and COOH-terminal truncation. J Cell Biol (1994) 1.80
Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition motif R-X-K/R-R. Virology (1992) 1.79
Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein. J Virol (2000) 1.79
Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus. J Mol Biol (2000) 1.79
The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO J (1985) 1.76
The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J Gen Virol (1995) 1.76
Fusion between cell membrane and liposomes containing the glycoproteins of influenza virus. Virology (1980) 1.73
Release of viral glycoproteins during Ebola virus infection. Virology (1998) 1.73
Post-translational glycosylation of coronavirus glycoprotein E1: inhibition by monensin. EMBO J (1982) 1.67
Site-specific mutagenesis identifies three cysteine residues in the cytoplasmic tail as acylation sites of influenza virus hemagglutinin. J Virol (1991) 1.65
Carbohydrates of influenza virus. Structural elucidation of the individual glycans of the FPV hemagglutinin by two-dimensional 1H n.m.r. and methylation analysis. EMBO J (1985) 1.64
The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer. Virology (1998) 1.62
Neuraminidase is essential for fowl plague virus hemagglutinin to show hemagglutinating activity. Virology (1995) 1.62
Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin. Virology (1995) 1.60
A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products. J Virol (2001) 1.59
Membrane association induces a conformational change in the Ebola virus matrix protein. EMBO J (2000) 1.59
Recognition of viral glycoproteins by influenza A-specific cross-reactive cytolytic T lymphocytes. J Exp Med (1980) 1.58
Role of conserved glycosylation sites in maturation and transport of influenza A virus hemagglutinin. J Virol (1993) 1.58
Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease. J Clin Invest (1993) 1.57
Ultrastructural organization of recombinant Marburg virus nucleoprotein: comparison with Marburg virus inclusions. J Virol (2000) 1.55
Coronavirus glycoprotein E1, a new type of viral glycoprotein. J Mol Biol (1981) 1.55
Sequence analysis of the Marburg virus nucleoprotein gene: comparison to Ebola virus and other non-segmented negative-strand RNA viruses. J Gen Virol (1992) 1.53
Carbohydrate structure of Marburg virus glycoprotein. Glycobiology (1992) 1.48
Cotranslational and posttranslational processing of viral glycoproteins. Curr Top Microbiol Immunol (1980) 1.47
Plasma membrane lipids and parainfluenza virus assembly. Virology (1970) 1.44
Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry. Virology (1994) 1.44
Altered budding site of a pantropic mutant of Sendai virus, F1-R, in polarized epithelial cells. J Virol (1990) 1.43
Endoproteolytic cleavage of its propeptide is a prerequisite for efficient transport of furin out of the endoplasmic reticulum. J Biol Chem (1995) 1.43
Proteolytic processing of Marburg virus glycoprotein. Virology (2000) 1.43
Coronaviridae. Intervirology (1983) 1.42
Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and Kex2. J Virol (1994) 1.41
Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. Virology (1987) 1.40
Chemical composition of the parainfluenza virus SV5. Virology (1969) 1.39
Human influenza virus hemagglutinin with high sensitivity to proteolytic activation. J Virol (1991) 1.38
Delta-peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus. Virology (1999) 1.37
Termini of all mRNA species of Marburg virus: sequence and secondary structure. Virology (1996) 1.36
The role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cells. J Virol (1997) 1.35
The oligosaccharides of influenza virus hemagglutinin expressed in insect cells by a baculovirus vector. Virology (1990) 1.34
Carbohydrates of influenza virus. I. Glycopeptides derived from viral glycoproteins after labeling with radioactive sugars. J Virol (1977) 1.33
The glycoprotein of influenza C virus is the haemagglutinin, esterase and fusion factor. J Gen Virol (1988) 1.33
The nucleotide sequence of the L gene of Marburg virus, a filovirus: homologies with paramyxoviruses and rhabdoviruses. Virology (1992) 1.32
Inhibition of proteolytic cleavage of the hemagglutinin of influenza virus by the calcium-specific ionophore A23187. EMBO J (1984) 1.32
A comparison of immune cytolysis and virus-induced fusion of sensitive and resistant cell types. Proc Soc Exp Biol Med (1969) 1.31
The carboxyterminus of the hemagglutinin-neuraminidase of Newcastle disease virus is exposed at the surface of the viral envelope. Virus Res (1984) 1.31
Antibody response to the M2 protein of influenza A virus expressed in insect cells. J Gen Virol (1993) 1.31